Triptolide Inhibits Expression of Inflammatory Cytokines and Proliferation of Fibroblast-like Synoviocytes Induced by IL-6/sIL-6R-Mediated JAK2/STAT3 Signaling Pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Triptolide Inhibits Expression of Inflammatory Cytokines and Proliferation of Fibroblast-like Synoviocytes Induced by IL-6/sIL-6R-Mediated JAK2/STAT3 Signaling Pathway
Authors
Keywords
-
Journal
Current Medical Science
Volume 41, Issue 1, Pages 133-139
Publisher
Springer Science and Business Media LLC
Online
2021-02-14
DOI
10.1007/s11596-020-2302-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combination of 4-hydroperoxy cyclophosphamide and methotrexate inhibits IL-6/sIL-6R-induced RANKL expression in fibroblast-like synoviocytes via suppression of the JAK2/STAT3 and p38MAPK signaling pathway
- (2018) Hong-Qing Niu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Fabrication of a triptolide-loaded and poly-γ-glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritis
- (2018) Li Zhang et al. International Journal of Nanomedicine
- Triptolide prevents osteoarthritis via inhibiting hsa-miR-20b
- (2018) Kejun Qian et al. INFLAMMOPHARMACOLOGY
- RHAMM induces progression of rheumatoid arthritis by enhancing the functions of fibroblast-like synoviocytes
- (2018) Jing Wu et al. BMC MUSCULOSKELETAL DISORDERS
- Carvacrol suppresses inflammatory responses in rheumatoid arthritis fibroblast-like synoviocytes
- (2018) Yu Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection
- (2018) Martina Biggioggero et al. Drug Design Development and Therapy
- Ellipticine inhibits the proliferation and induces apoptosis in rheumatoid arthritis fibroblast-like synoviocytes via the STAT3 pathway
- (2017) Hui-long Wen et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Triptolide inhibits the migration and invasion of rheumatoid fibroblast-like synoviocytes by blocking the activation of the JNK MAPK pathway
- (2016) Yanlong Yang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Identification of key regulators for the migration and invasion of rheumatoid synoviocytes through a systems approach
- (2013) S. You et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes
- (2013) Jung-Yoon Choe et al. ARTHRITIS RESEARCH & THERAPY
- Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2
- (2012) Wei Gao et al. ANNALS OF THE RHEUMATIC DISEASES
- Drugs and the skin: psoriasis
- (2012) James M. Ritter BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Melittin enhances apoptosis through suppression of IL-6/sIL-6R complex-induced NF-κB and STAT3 activation and Bcl-2 expression for human fibroblast-like synoviocytes in rheumatoid arthritis
- (2011) Seong-Kyu Kim et al. JOINT BONE SPINE
- Influence of Janus Kinase Inhibition on Interleukin 6-mediated Induction of Acute-phase Serum Amyloid A in Rheumatoid Synovium
- (2011) K. MIGITA et al. JOURNAL OF RHEUMATOLOGY
- Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11
- (2009) Sook Kyung Chang et al. IMMUNOLOGICAL REVIEWS
- Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis
- (2009) Beatrix Bartok et al. IMMUNOLOGICAL REVIEWS
- Expression of proinflammatory cytokines in osteoarthritis of the temporomandibular joint
- (2008) Rolando Vernal et al. ARCHIVES OF ORAL BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now